Resideo Stock Soars With Strong ADI And Products Revenue

By John Honovich, Published Nov 10, 2020, 09:23am EST (Info+)

Resideo's stock has soared 60%+ since the company's Q3 2020 financials were released last week.

IPVM Image

Inside this note, we examine Resideo's financial examining both the ADI distribution and Honeywell Homes sides of the business.

ADI ******

***'* ******* ******* **** *.*% ** Q3 ****, * ****** ****** ****** building *** *** ** *********** **** ADI ******** ** ****** ***** **** ***** ******** ***'* ***** **** **** **%.

*** ****, *** ******* ** ************ improvements ** ****** ******* *** ******** acquisitions:

** ***, ***** *********** **** ******* systems ************, *-******** *********** *** ******** M&A.

**** *******, *** ******* **** **** were ***** ** ** **** **** calling:

** *** ********* **** ************ ** some ***** *********** **** ******** *********.

*** ** ***** **** *** ***** taking ***** *** ******* ****** (***** LTS, ***, ***.) **** **** ** outbound. ** *** ****** **** *** really **** ****, **** ***** **** share.

ADI ******* **** ********* **** ********

******* ******* **** *******'* *** ********** is ****** *** **** **** ********* Home / ******* ********:

* ***** ** **** * **** opportunity ** **** * ******* ************* between *** *** ******** & ********* group. *** ******* ** **** -- as ******** & ********* ***** ** their ******* **** **** ** *** future *** **** ** *** **** time, ********** **** *** ** **** further **** ***. *** ** ****'* happening. *** **** ***** ****, ** you **** *********, *** * ********* about *** ******** **** ** *****. And * **** **** *** ****** are *** ******* **** ****** ********, and **'** *********** **** ** * big ***

**** ** *** *** **, ***-*******, ADI **** ******* ********* ********. ** the **** ****, ******** ********* **** ones *** **** ******* ***** *** risks ******** **** ***'* ***** ********.

Products / ********* *****

*** ******** **** *** *** ****** turnaround, **** ** ******* ** **% year **** ****, ********** ** ****** ******* ********* **%. *** ******* cited "******** *** ****** ******, ************ in *** ******** *** ******* *******."

************, *** ******* ********* **************:

** **** *********** ******** & ********* to ********* *********** *** ******* **** management. ***** ******* *** ******** ** foster ************* ****** *** ****** ******* portfolio *** ********* ******** ******** ** bringing ********** *** ******** ** ****** quickly *** **** ***********, ***** ******** we *** ******* **** *** ***** of *** *********.

** ** *** ***** *** ******* products / ********* **** **** ** we ****** ***** ***** *** ******* demand *** **** ******** *** ******* markets *** **** ****** ** *** pandemic / ******* **** ******** ** this ** ****** ******* *******.

Stock *****

**** ***** *******, *******'* ***** **** up **** ~$** *** ***** ** over $**, ** ***** *****:

IPVM Image

Still *** ***** ***

** *** ******** ****, *** *******'* stock ** ***** ******* ~**% **** than **** ** *** **** *** last ****:

IPVM Image

Comments (0)

Login to read this IPVM report.
Why do I need to log in?
IPVM conducts reporting, tutorials and software funded by subscriber's payments enabling us to offer the most independent, accurate and in-depth information.
Loading Related Reports